CJC-1295 (No DAC) / GHRP-2Understand the science
Following two signals inside cultured pituitary cells
2 numbered sourcesSource years 1998, 2024
Peptide bonds hold amino acids together in short chains called peptides. When a chain activates a receptor, cells can relay the message through molecules inside the cell. CJC-1295 (No DAC) / GHRP-2 lists two peptides expected to enter the growth hormone system at different points. The no-DAC label commonly means modified GHRH(1–29). GHRP-2 is a synthetic peptide that stimulates the growth hormone secretagogue pathway. [1, 2]
An older laboratory study explored how GHRP-2 and growth hormone–releasing hormone (GHRH) act on cells from human pituitary tumors that secrete growth hormone. Researchers cultured cells from seven tumors. They measured growth hormone release, calcium levels inside cells and a signaling molecule called cyclic AMP. They also used experimental blockers to help work out which internal signals each response depended on. [2]
The investigators concluded that GHRH primarily acted through cyclic AMP in these cells, while GHRP-2 worked mainly through a pathway involving protein kinase C, an enzyme that helps pass signals onward. Both compounds could increase intracellular calcium. This is a useful distinction because two signals can have different starting points and still share some of the machinery involved in releasing a hormone. [2]
No recent primary study of the exact no-DAC and GHRP-2 pair was identified. The 1998 research used a different GHRH molecule and cells taken from hormone-secreting tumors, a particular disease setting. It gives a mechanistic reason to compare the two signaling routes. The paper cannot describe how a mixture behaves in a vial, how the catalog pair behaves in a healthy pituitary, or what outcomes it might produce in humans. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
